Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men
Title:
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men
Author:
Giuliano, Anna R. Wilkin, Timothy Bautista, Oliver M. Cheon, Kyeongmi Connor, Laurie Dubey, Sheri Luxembourg, Alain Rawat, Sonali Shaw, Anita Velicer, Christine Vendetti, Neika Tu, Yingmei
Appeared in:
Contemporary clinical trials
Paging:
Volume 115 () nr. C pages p.
Year:
2022
Contents:
Publisher:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, The Author(s)